
Increased risk of serious heart-related problems and cancer with Tofacitinib
Initial safety trial results find increased risk of serious heart-related problems and cancer with arthritis and ulcerative colitis medicine Xeljanz, Xeljanz XR (tofacitinib)
FDA will evaluate the trial results
FDA.GOV